Oxford Gene Technology (OGT), a provider of clinical genetics and diagnostic solutions designed to advance molecular medicine, has launched its next-generation targeted sequencing service.
The new offering takes advantage of the company's high-quality processes and in-house bioinformatics experience to provide a complete targeted sequencing solution.
This includes whole exome sequencing, as well as the custom targeted sequencing of any genomic region of interest.
This new service is designed to make it easy for all researchers to obtain the benefits of next-generation sequencing (NGS) without the need for extensive technical knowledge, equipment or bioinformatics resources.
The planning of an NGS experiment is a complex process, with many critical components to consider, including protocol choice, library design, capture method, instrumentation and coverage.
Optimising these steps is essential for generating accurate, insightful data, according to the company.
OGT claims that its offering - known as the Genefficiency Genomic Services - helps to ensure that each study yields meaningful, reliable results.
The average NGS experiment generates several hundred megabases of sequence, which can be an obstacle to researchers in terms of data management, storage and analysis.
To meet this challenge, OGT's in-house bioinformatics team performs all the standard alignment and quality control processing, maximising data quality, as well as the additional filtering of the information.
The company's entry offering provides results as a user-friendly html report that places features such as insertions, deletions and single nucleotide polymorphisms into context.
This includes the identification of affected genes and proteins, possible disease associations and links to external databases.
